Trial Profile
Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in patients with acute coronary syndrome (TACSI trial)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2023
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Cardiovascular disorders; Myocardial infarction; Stroke
- Focus Therapeutic Use
- Acronyms TACSI trial
- 26 Oct 2023 Planned primary completion date changed from 1 Jun 2022 to 1 Jun 2025.
- 18 Jan 2023 Trial design published in the American Heart Journal
- 06 Apr 2021 Planned primary completion date changed from 1 Jun 2021 to 1 Jun 2022.